Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three-month periods ended March 31, 2023 and 2022, were as follows (in thousands):

	Three Months Ended
	March 31,
	2023		2022
Net sales
Cardiovascular	$	287,976	$	266,936
Endoscopy		9,589		8,479
Total net sales		297,565		275,415
Income from operations
Cardiovascular		23,934		13,126
Endoscopy		2,449		2,107
Total income from operations		26,383		15,233
Total other expense — net		(883)		(1,062)
Income tax expense		4,797		3,626
Net income	$	20,703	$	10,545